About Seneca Biopharma, Inc
Seneca Biopharma, Inc., a clinical stage biopharmaceutical company, develops novel treatments for diseases of high unmet medical needs. The company’s stem cell-based technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types. It is developing NSI-566, which has completed Phase II clinical trial for treating amyotrophic lateral sclerosis disease, as well as in Phase II clinical trial for the treatment of chronic ischemic stroke and in Phase I clinical trial for the treatment of chronic spinal cord injury; and NSI-189 that has completed Phase II clinical trials for the treatment of major depressive disorder. The company was formerly known as Neuralstem, Inc. and changed its name to Seneca Biopharma, Inc. in October 2019. Seneca Biopharma, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. Address: 20271 Goldenrod Lane, Germantown, MD, United States, 20876
Seneca Biopharma, Inc News and around…
Latest news about Seneca Biopharma, Inc (SNCA) common stock and company :
Seneca Biopharma(NASDAQ: SNCA) shares are trading higher after the company announced the successful approval of a merger with ...
Gainers Renalytix AI (NASDAQ:RNLX) stock moved upwards by 20.93% to $30.5 during Thursday's pre-market session. The ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Thursday's here and we're taking a look at the biggest pre-market movers investors will want to know about before the opening bell. The post Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Thursday Morning appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner Stock Prodigy Who Found NIO at $2… Says Buy THIS Now
Privately-heldLeading BioSciences Incentered into a definitive agreementfor a reverse merger withSeneca ...
Gainers GT Biopharma (NASDAQ:GTBP) stock increased by 17.4% to $10.32 during Friday's regular session. Trading ...
Gainers DiaMedica Therapeutics (NASDAQ:DMAC) shares increased by 6.17% to $9.98 during Thursday's after-market session. DiaMedica ...
Gainers International General Insurance Holdings Ltd. (NASDAQ: IGIC) rose 758% to $70.00 in pre-market trading. IGI recently ...
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) climbed 64.2% to $5.73. Cellect Biotechnology and Quoin Pharmaceuticals reported ...
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 73% to $6.03 in pre-market trading. Cellect Biotechnology and Quoin ...
Gainers HighPoint Resources Corporation (NYSE: HPR) shares jumped 118.8% to close at $10.83 on Wednesday. WISeKey International ...
Gainers Aptose Biosciences (NASDAQ:APTO) shares rose 82.83% to $6.71 during Wednesday's regular session. As of 12:32 ...
Gainers Aptose Biosciences Inc. (NASDAQ: APTO) rose 77.3% to $6.51 after the company reported Q4 earnings results. Hall of Fame ...
Gainers Hall of Fame Resort & Entertainment Company (NASDAQ: HOFV) rose 83.6% to $7.40 in pre-market trading after the company ...
Gainers Aptose Biosciences (NASDAQ:APTO) shares rose 24.79% to $4.58 during Tuesday's after-market session. Today's trading volume ...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 231.8% to close at $7.10 on Monday after the company announced a merger ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Seneca Biopharma (SNCA) stock is on the rise as investors prepare for an upcoming meeting covering a merger and reverse stock split. The post SNCA Stock: Seneca Biopharma Shares Rocket Ahead of Merger, Reverse Stock Split Meeting appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner Stock Prodigy Who Found NIO at $2… Says Buy THIS Now
Gainers Seneca Biopharma (NASDAQ:SNCA) shares moved upwards by 24.08% to $2.04 during Monday's regular session. ...
Before 10 a.m. ET on Monday, 136 companies hit new 52-week highs. Facts of Interest: Cisco Systems ...
Gainers Support.com, Inc. (NASDAQ: SPRT) shares climbed 243.8% to $7.35 after the company announced a merger agreement with ...
The Price And Volume Action In Seneca Biopharma's Stock Today Seneca Biopharma (NASDAQ:SNCA) is currently up 41.97% to a price of ...
Gainers Seneca Biopharma (NASDAQ:SNCA) shares increased by 34.14% to $2.2 during Monday's pre-market session. The ...
Gainers Support.com, Inc. (NASDAQ: SPRT) rose 97.6% to $4.23 in pre-market trading. Bitcoin miner Greenidge Generation Holdings ...
Gainers SenesTech (NASDAQ:SNES) shares rose 83.92% to $3.09 during Friday's pre-market session. The company's ...
Gainers Infinity Pharmaceuticals (NASDAQ:INFI) shares increased by 15.93% to $3.71 during Thursday's regular ...
Gainers Solid Biosciences Inc. (NASDAQ: SLDB) shares surged 41.8% to close at $9.74 on above-average session volume. TimkenSteel ...
Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) shares jumped 64.1% to $3.8899. Vascular Biogenics Ltd. (NASDAQ: VBLT) gained 37.7% to ...
Gainers Vascular Biogenics Ltd. (NASDAQ: VBLT) rose 67.3% to $3.73 in pre-market trading. Vascular Biogenics, on Monday, announced ...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Seneca Biopharma, Inc (SNCA) is a NASDAQ Common Stock listed in Biotechnology, Common Stock, Healthcare
